Mycoplasmal Arthritis

  • Luis E. Vega
  • Luis R. Espinoza


Mycoplasmas are free-living microorganisms that belong to the Mollicutes class (cell wall–free bacteria), ubiquitous, and primarily commensals residing on mucosal surfaces as part of microbiomes of healthy people, but sometimes they may produce diseases in the respiratory, genitourinary, and musculoskeletal systems. These microorganisms may be pathogenic agents in immunocompetent and immunosuppressed individuals. Septic arthritis and reactive arthritis associated with these microorganisms have been described. The clinical manifestations are acute, and the articular pattern can be monoarthritis or polyarthritis. Diagnosis is made with the use of laboratory tests such as serology, culture in special medium, and molecular technology (PCR). Macrolides and related antibiotics are therapies of first choice.


Mycoplasmal arthritis Mycoplasma pneumonia–associated arthritis Arthritis associated with genital mycoplasma 


  1. 1.
    Holzman RS, Simberkoff MS. Mycoplasma diseases. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 8th ed: Elsevier Saunders; 2015.Google Scholar
  2. 2.
    Waites KB, Taylor-Robinson D. Mycoplasma and ureaplasma. In: Versalovic J, Carroll KC, Funke G, et al., editors. Manual of clinical microbiology, vol. 1. 10th ed: ASM Press; 2011.Google Scholar
  3. 3.
    Cassel GH, Cole BC. Mycoplasma as agents of human disease. N Engl J Med. 1981;8:80–9.CrossRefGoogle Scholar
  4. 4.
    Taylor-Robinson D. Infections due to species of Mycoplasma and Ureaplasma: an update. Clin Infect Dis. 1996;23:671–84.CrossRefGoogle Scholar
  5. 5.
    Daley GM, Russell DB, Tabrizi SN, McBride J. Mycoplasma genitalium: a review. Int J STD AIDS. 2014;25:475–87.CrossRefGoogle Scholar
  6. 6.
    Hayes MM, Li BJ, Wear DJ, Lo SC. Pathogenicity of Mycoplasma fermentans and Mycoplasma penetrans in experimentally infected chicken embryos. Infect Immun. 1996;64:3419–24.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Kokkayil P, Dhawan B. Ureaplasma: current perspectives. Indian J Med Microbiol. 2015;33:205–14.CrossRefGoogle Scholar
  8. 8.
    Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev. 2005;18:757–89.CrossRefGoogle Scholar
  9. 9.
    Wu JR, Wang B, Zhou LJ, Xie YX, Xu JS, Chen LS, Yang T, Guo HX. Mycoplasmas infection in male HIV/AIDS patients in Jiangsu, China. Microb Pathog. 2013;63:54–8.CrossRefGoogle Scholar
  10. 10.
    Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697–728.CrossRefGoogle Scholar
  11. 11.
    Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J Infect Chemother. 2010;16:162–9.CrossRefGoogle Scholar
  12. 12.
    Lambert HP. Syndrome with joint manifestations in association with mycoplasma pneumonia. Br Med J. 1968;3:156–7.CrossRefGoogle Scholar
  13. 13.
    Hernadez LA, Urquhart GED, Dick CLW. Mycoplasma pneumonia infection and arthritis in man. Br Med J. 1977;2:14–6.CrossRefGoogle Scholar
  14. 14.
    Ponka A. Arthritis associated with mycoplasma pneumoniae infection. Scand J Rheumatol. 1979;8:27–32.CrossRefGoogle Scholar
  15. 15.
    Davis CP, Cochran S, Lisse J, Buck G, DiNuzzo AR, Weber T, Reinarz JA. Isolation of Mycoplasma pneumoniae from synovial fluid samples in a patient with pneumonia and polyarthritis. Arch Intern Med. 1988;148:969–70.CrossRefGoogle Scholar
  16. 16.
    Leli C, Mencacci A, Latino MA, Clerici P, Rassu M, Perito S, et al. Prevalence of cervical colonization by Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium in childbearing age women by a commercially available multiplex real-time PCR: an Italian observational multicentre study. J Microbiol Immunol Infect. 2018;51:220–5.CrossRefGoogle Scholar
  17. 17.
    Bojović J, Strelić N, Pavlica L. Reiter's syndrome--disease of young men-- analysis of 312 patients. Med Pregl. 2014;67:222–30.CrossRefGoogle Scholar
  18. 18.
    Chrisment D, Machelart I, Wirth G, Lazaro E, Greib C, Pellegrin JL, Bébéar C, Peuchant O. Reactive arthritis associated with Mycoplasma genitalium urethritis. Diagn Microbiol Infect Dis. 2013;77:278–9.CrossRefGoogle Scholar
  19. 19.
    Furr PM, Taylor-Robinson D, Webster AD. Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years. Ann Rheum Dis. 1994;53:183–7.CrossRefGoogle Scholar
  20. 20.
    Lehmer RR, Andrews BS, Robertson JA, Stanbridge EJ, de la Maza L, Friou GJ. Clinical and biological characteristics of Ureaplasma urealyticum induced polyarthritis in a patient with common variable hypogammaglobulinaemia. Ann Rheum Dis. 1991;50:574–6.CrossRefGoogle Scholar
  21. 21.
    George MD, Cardenas AM, Birnbaum BK, Gluckman SJ. Ureaplasma septic arthritis in an immunosuppressed patient with juvenile idiopathic arthritis. J Clin Rheumatol. 2015;21:221–4.CrossRefGoogle Scholar
  22. 22.
    Goulenok TM, Bialek S, Gaudart S, Bébéar C, Fantin B. Ureaplasma urealyticum destructive septic arthritis in a patient with systemic lupus erythematosus after rituximab therapy. Joint Bone Spine. 2011;78:323–4.CrossRefGoogle Scholar
  23. 23.
    Farrell JJ, Larson JA, Akeson JW, Lowery KS, Rounds MA, Sampath R, et al. Ureaplasma parvum prosthetic joint infection detected by PCR. J Clin Microbiol. 2014;52:2248–50.CrossRefGoogle Scholar
  24. 24.
    Ramirez AS, Rosas A, Hernández-Berian JA, et al. Relationship between rheumatoid arthritis and Mycoplasma pneumoniae: a case-control study. Rheumatology (Oxford). 2005;44:912–4.CrossRefGoogle Scholar
  25. 25.
    McEvoy T. Minocycline: rheumatoid arthritis. Hosp Pharm. 2016;51:535–8.CrossRefGoogle Scholar
  26. 26.
    O'Dell JR. Is there a role for antibiotics in the treatment of patients with rheumatoid arthritis? Drugs. 1999;57:279–82.CrossRefGoogle Scholar
  27. 27.
    Schaeverbeke T, Gilroy CB, Bébéar C, Dehais J, Taylor-Robinson D. Mycoplasma fermentans, but not M penetrans, detected by PCR assays in synovium from patients with rheumatoid arthritis and other rheumatic disorders. J Clin Pathol. 1996;49:824–8.CrossRefGoogle Scholar
  28. 28.
    Horowitz S, Evinson B, Borer A, Horowitz J. Mycoplasma fermentans in rheumatoid arthritis and other inflammatory arthritides. J Rheumatol. 2000;27:2747–53.PubMedGoogle Scholar
  29. 29.
    Gilroy CB, Keat A, Taylor-Robinson D. The prevalence of Mycoplasma fermentans in patients with inflammatory arthritides. Rheumatology (Oxford). 2001;40:1355–8.CrossRefGoogle Scholar
  30. 30.
    Kawahito Y, Ichinose S, Sano H, Tsubouchi Y, Kohno M, Yoshikawa T, Tokunaga D, Hojo T, Harasawa R, Nakano T, Matsuda K. Mycoplasma fermentans glycolipid-antigen as a pathogen of rheumatoid arthritis. Biochem Biophys Res Commun. 2008;369:561–6.CrossRefGoogle Scholar
  31. 31.
    Johnson SM. The importance of B-cells and ecto-5'nucleotidase in Mycoplasma fermentans infection and the relevance to rheumatoid arthritis. Immunology. 2008;123:187–96.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Rivera A, Yáñez A, León-Tello G, Gil C, Giono S, Barba E, Cedillo L. Experimental arthritis induced by a clinical Mycoplasma fermentans isolate. BMC Musculoskelet Disord. 2002;3:15–21.CrossRefGoogle Scholar
  33. 33.
    Meseguer-Peinado MA, Acosta-Bogab B, Matas-Andreuc L, Codina-Graud G. Diagnóstico microbiológico de las infecciones por Mycoplasma. Enfermedades Infecciosas y Microbiologia Clínica. 2012;30(8):500–4.CrossRefGoogle Scholar
  34. 34.
    Waites KB, Xiao L, Paralanov V, Viscardi RM, Glass JI. Molecular methods for the detection of mycoplasma and ureaplasma infections in humans. J Mol Diagn. 2012;14:437–50.CrossRefGoogle Scholar
  35. 35.
    Beersma MF, Dirven K, van Dam AP, Templeton KE, Claas EC, Goossens H. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the “gold standard”. J Clin Microbiol. 2005;43:2277–85.CrossRefGoogle Scholar
  36. 36.
    Chen D, Zhang Y, Xu Y, Shen T, Cheng G, Huang B, et al. Comparison of chemiluminescence immunoassay, enzyme-linked immunosorbent assay and passive agglutination for diagnosis of Mycoplasma pneumoniae infection. Ther Clin Risk Manag. 2018;14:1091–7.CrossRefGoogle Scholar
  37. 37.
    Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect. 2003;9:263–73.CrossRefGoogle Scholar
  38. 38.
    Loens K, Ursi D, Goossens H, Ieven M. Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections. J Clin Microbiol. 2003;41:4915–23.CrossRefGoogle Scholar
  39. 39.
    Daxboeck F, Khanakah G, Bauer C, Stadler M, Hofmann H, Stanek G. Detection of Mycoplasma pneumoniae in serum specimens from patients with mycoplasma pneumonia by PCR. Int J Med Microbiol. 2005;295:279–85.CrossRefGoogle Scholar
  40. 40.
    Loens K, Goossens H, Ieven M. Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods. Eur J Clin Microbiol Infect Dis. 2010;29:1055–69.CrossRefGoogle Scholar
  41. 41.
    Michelow IC, Olsen K, Lozano J, Duffy LB, McCracken GH, Hardy RD. Diagnostic utility and clinical significance of naso- and oropharyngeal samples used in a PCR assay to diagnose Mycoplasma pneumoniae infection in children with community-acquired pneumonia. J Clin Microbiol. 2004;42:3339–41.CrossRefGoogle Scholar
  42. 42.
    Xiao L, Glass JI, Paralanov V, Yooseph S, Cassell GH, Duffy LB, Waites KB. Detection and characterization of human Ureaplasma species and serovars by real-time PCR. J Clin Microbiol. 2010;48:2715–23.CrossRefGoogle Scholar
  43. 43.
    Grau O, Kovacic R, Griffais R, Launay V, Montagnier L. Development of PCR-based assays for the detection of two human mollicute species: Mycoplasma penetrans and M hominis. Mol Cell Probes. 1994;8:139–47.CrossRefGoogle Scholar
  44. 44.
    Yoshida T, Maeda S, Deguchi T, Miyazawa T, Ishiko H. Rapid detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum organisms in genitourinary samples by PCR-microtiter plate hybridization assay. J Clin Microbiol. 2003;41:1850–5.CrossRefGoogle Scholar
  45. 45.
    Kong F, Ma Z, James G, Gordon S, Gilbert GL. Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR-based assays. J Clin Microbiol. 2000;38:1175–9.PubMedPubMedCentralGoogle Scholar
  46. 46.
    Povlsen K, Jensen JS, Lind I. Detection of Ureaplasma urealyticum by PCR and biovar determination by liquid hybridization. J Clin Microbiol. 1998;36:3211–6.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Lee AH, Ramanujam T, Ware P, Edelstein PH, Brooks JJ, Freundlich B, Schumacher HR Jr, et al. Molecular diagnosis of Ureaplasma urealyticum septic arthritis in a patient with hypogammaglobulinemia. Arthritis Rheum. 1992;35:443–8.CrossRefGoogle Scholar
  48. 48.
    Winchell JM, Thurman KA, Mitchell SL, Thacker WL, Fields BS. Evaluation of three real-time PCR assays for detection of Mycoplasma pneumoniae in an outbreak investigation. J Clin Microbiol. 2008;46:3116–8.CrossRefGoogle Scholar
  49. 49.
    Dumke R, Schurwanz N, Lenz M, Schuppler M, Luck C, Jacobs E. Sensitive detection of Mycoplasma pneumoniae in human respiratory tract samples by optimized real-time PCR approach. J Clin Microbiol. 2007;45:2726–30.CrossRefGoogle Scholar
  50. 50.
    Taylor-Robinson D, Bébéar C. Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections. J Antimicrob Chemother. 1997;40:622–3.CrossRefGoogle Scholar
  51. 51.
    Pereyre S, Goret J, Bébéar C. Mycoplasma pneumoniae: current knowledge on Macrolide resistance and treatment. Front Microbial. 2016;7:974–84.Google Scholar
  52. 52.
    Cao B, Qu JX, Yin YD, Eldere JV. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance. Clin Respir J. 2017;11:419–29.CrossRefGoogle Scholar
  53. 53.
    Wang QY, Li RH, Zheng LQ, Shang XH. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009-2013. J Microbiol Immunol Infect. 2016;49:359–62.CrossRefGoogle Scholar
  54. 54.
    Foschi C, Salvo M, Galli S, Moroni A, Cevenini R, Marangoni A. Prevalence and antimicrobial resistance of genital Mollicutes in Italy over a two-year period. New Microbiol. 2018;41:153–8.PubMedGoogle Scholar
  55. 55.
    Soni S, Horner P, Rayment M, Pinto-Sander N, Naous N, Parkhouse A, et al. 2018 BASHH UK national guideline for the management of infection with Mycoplasma genitalium. Available from:

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Luis E. Vega
    • 1
  • Luis R. Espinoza
    • 2
  1. 1.Department of MedicineHospital Central de la Fuerza AéreaLimaPeru
  2. 2.LSU Health Sciences at New OrleansLouisiana State UniversityNew OrleansUSA

Personalised recommendations